← Go back

Applying New Endocrine and Targeted Agents to the Treatment of Hormone Receptor Positive, HER2 Negative Breast Cancer

Mariana Chavez-McGregor, MD, MSc, FASCO

This content is restricted to members only.

Login Here

Forgot Password?

Please enter your email. The password reset link will be provided in your email.

GET STARTED NOW

Choose the Subscription that’s Best for You

MEC Basic

  • Access to Library of Conference Presentations in PDF format
  • View Non-CME/CE On Demand Videos at $9.99/ea.
  • Purchase On-Demand CME/CE at full price

Cost: FREE

Subscribe Now

MEC Plus

  • Access to Library of Conference Presentations in PDF format
  • View Unlimited Non-CME/CE On Demand Videos
  • 15% Discount on any On-Demand CME/CE purchase

Cost: $299 Annually Healthcare Professionals
Cost: $499 Annually Industry Professionals

Subscribe Now